Emil Macek

M+W Group

M+W Group with its origin in Germany and a history of more than 100 years has reorganised its activities in 2018, thereby creating two, distinct companies ‘Exyte' and ‘M+W': Exyte comprises all core business activities, which include Advanced Technology Facilities (ATF), Biopharma & Life Sciences, Data Centers (DTC) and Regional Specific Business (RSB) in defined target countries. M+W comprises all other business activities, which are mainly related to energy projects. The re-grouping does not have any influence on the execution of ongoing projects or on customer engagements, respectively. M+W Group, which holds 100% of Exyte and 100% of M+W, is owned by the Stumpf Group.